|
GTDC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.413200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.799400E-03 |
| Normal-vs-Stage2 |
5.460300E-02 |
| Normal-vs-Stage3 |
2.569100E-04 |
| Normal-vs-Stage4 |
9.786200E-02 |
| Stage1-vs-Stage2 |
9.445600E-01 |
| Stage1-vs-Stage3 |
1.357180E-01 |
| Stage1-vs-Stage4 |
5.654000E-01 |
| Stage2-vs-Stage3 |
3.554400E-01 |
| Stage2-vs-Stage4 |
6.408200E-01 |
| Stage3-vs-Stage4 |
1.062360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.016500E-04 |
| Normal-vs-AfricanAmerican |
1.458620E-01 |
| Normal-vs-Asian |
1.544590E-01 |
| Caucasian-vs-AfricanAmerican |
3.803000E-01 |
| Caucasian-vs-Asian |
9.292800E-01 |
| AfricanAmerican-vs-Asian |
6.527600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.963800E-04 |
| Normal-vs-Female |
6.135000E-03 |
| Male-vs-Female |
5.873800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.985700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.595400E-04 |
| Normal-vs-Age(61-80Yrs) |
7.499100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.812800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.679200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.406000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.944600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.487600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.395000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.439400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.612200E-01 |
| Normal-vs-Grade 2 |
2.160400E-04 |
| Normal-vs-Grade 3 |
1.532100E-02 |
| Normal-vs-Grade 4 |
5.813100E-04 |
| Grade 1-vs-Grade 2 |
1.936390E-02 |
| Grade 1-vs-Grade 3 |
1.391630E-01 |
| Grade 1-vs-Grade 4 |
1.480280E-02 |
| Grade 2-vs-Grade 3 |
1.281750E-01 |
| Grade 2-vs-Grade 4 |
7.017600E-01 |
| Grade 3-vs-Grade 4 |
1.133650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.602500E-02 |
| Normal-vs-ccB subtype |
3.85939999958396E-07 |
| ccA subtype-vs-ccB subtype |
2.222300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.191100E-04 |
| Normal-vs-N1 |
3.345600E-01 |
| N0-vs-N1 |
8.748600E-01 |
|
|
